- Investigator
- Francesco Franchi
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Research at a glance
Top areas of exploration
- Platelet Aggregation Inhibitors , 79 publications
- Percutaneous Coronary Intervention , 47 publications
- Purinergic P2Y Receptor Antagonists , 41 publications
- Clopidogrel , 35 publications
Research activity
Active clinical trials
- Investigator
- Francesco Franchi
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
- Investigator
- Francesco Franchi
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
My publications
Filter publications
128 publications
2024
Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
Thrombosis and haemostasis
PubMed • Publisher's site2024
The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity.
Thrombosis and haemostasis
PubMed • Publisher's site2023
Bivalirudin in acute coronary syndromes.
Expert review of cardiovascular therapy
PubMed • Publisher's site2023
Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor
JACC: Cardiovascular Interventions
Publisher's site2023
Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of Bentracimab.
Clinical pharmacokinetics
PubMed • Publisher's site